Advertisement

Metformin monotherapy in lean women with polycystic ovary syndrome

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      This study was carried out to compare ovulation and pregnancy rates in response to metformin therapy in lean and obese women with polycystic ovary syndrome (PCOS). A total of 34 (17 lean and 17 obese) women with PCOS were treated with 500 mg metformin 3 times daily for 12 weeks. In the lean and obese groups, the mean body mass index was 24 and 36, and the mean fasting insulin concentrations were 12 and 21 mIU/l respectively. There was no difference between the two groups as regarding age, DHEA-S, androstenedione, 17-OH progesterone and LH concentrations. In the lean and obese groups 15/17 women (88%) and 5/17 women (29%) ovulated while 11/17 women (65%) and 3/17 women (18%) conceived respectively. Comparison between the groups was found to be statistically significant. Metformin monotherapy is very effective in improving ovulation and pregnancy rates in lean women with PCOS as compared with obese women.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Burghen GA
        • Givens JR
        • Kitabchi AE
        Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.
        Journal of Clinical Endocrinology and Metabolism. 1980; 50: 113-116
        • Cheang KI
        • Nestler JE
        Should insulin-sensitising drugs be used in the treatment of polycystic ovary syndrome?.
        Reproductive BioMedicine Online. 2004; 8: 440-447
        • Costello MF
        • Eden JA
        A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.
        Fertility and Sterility. 2003; 79: 1-13
        • Date PO
        • Tambo T
        • et al.
        Body weight, hyperinsulinaemia and gonadotrophin levels in the polycystic ovarian syndrome: evidence of two distinct populations.
        Fertility and Sterility. 1992; 58: 487-491
        • Dunaif A
        • Segal KR
        • et al.
        Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome.
        Diabetes. 1989; 38: 1165-1174
        • Dunaif A
        • Thomas A
        Current concepts in the polycystic ovary syndrome.
        Annual Review of Medicine. 2001; 52: 401-419
        • Dunaif A
        • Segal KR
        • Shelley DR
        Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.
        Diabetes. 1992; 41: 1257-1262
        • Fleming R
        • Hopkinson ZE
        • Wallace AM
        • et al.
        Ovarian function and metabolic factors in women with oligomenorrhoea treated with metformin in a randomized double blind placebo-controlled trial.
        Journal of Clinical Endocrinology and Metabolism. 2002; 87: 569-574
        • Franks S
        Polycystic ovary syndrome.
        New England Journal of Medicine. 1995; 333: 853-861
        • Gambineri A
        Obesity and the PCO syndrome.
        International Journal of Obesity and Related Metabolic Disorders. 2002; 26: 883-896
        • Grulet H
        • Hecarf AC
        • et al.
        Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
        Clinical Endocrinology (Oxford). 1993; 41: 473-481
        • Ibanez L
        • Valls C
        • Ferrer A
        • Marcos MV
        Sensitization to insulin induces ovulation in non-obese adolescents with anovulatory hyperandrogenism.
        Journal of Clinical Endocrinology and Metabolism. 2001; 86: 3595-3598
        • Iuorno J
        • Nestler E
        Insulin lowering drugs in polycystic ovary syndrome.
        Obstetrics and Gynecology Clinics. 2001; 28: 153-164
        • Lord J
        • Flight I
        • Norman R
        Systematic review of insulin sensitizing agents.
        Cochrane Database System Review. 2003; 3 (CD003053.)
        • Morales AJ
        • Laughlin GA
        • et al.
        Insulin, somatotropic and leutinizing harmone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
        Journal of Clinical Endocrinology and Metabolism. 1996; 81: 2854-2864
        • Nestler JE
        • Jakubowicz DJ
        Decrease in ovarian cytochrome p450 17 alpha activity and serum free testosterone after reduction in insulin secretion in women with polycystic ovary syndrome.
        New England Journal of Medicine. 1996; 335: 617-623
        • Nestler J
        • Jakubowicz J
        Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian p450c17 alpha activity, and serum androgens.
        Journal of Clinical Endocrinology and Metabolism. 1997; 82: 4075-4079
        • Nestler JE
        • Strauss 3rd JF
        Insulin as an effector of human ovarian and adrenal steroid metabolism.
        Endocrinology and Metabolism Clinics of North America. 1991; 20: 807-823
        • Nestler JE
        • Jakubowicz DJ
        • Evans WS
        • et al.
        Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome.
        New England Journal of Medicine. 1998; 338: 1876-1880
        • Stadtmauer LA
        • Toma SK
        • Riehl RM
        • Talbert LM
        Impact of metformin therapy on ovarian stimulation and outcome in ‘coasted’ patients with polycystic ovary syndrome undergoing in-vitro fertilization.
        Reproductive BioMedicine Online. 2002; 5: 112-116

      Biography

      The author is presently working as consultant obstetrician and gynaecologist at the Mafraq Hospital in Abu-Dhabi. She obtained her MD from Osmania University, India in 1983, and worked as assistant professor there until 1989. She obtained her Membership from the Royal College, London in 1996. Her major areas of research are obesity, polycystic ovary and gestational diabetes. Her publication on morbid obesity and pregnancy won the Best Prize Paper award for the year 2001 from the International Journal of Gynaecology and Obstetrics, International Federation of Obstetrics and Gynaecology.